Skip to content
Search

Latest Stories

NICE renews calls for greater use of community pharmacy services

A latest draft quality standard from the National Institute of Health and Care Excellence (NICE) calls for greater use of community pharmacy services in existing care and referral pathways.

Published today, ‘Community pharmacies: promoting health and wellbeing’ quality standard highlights how community pharmacy teams could play a greater role in health promotion, prevention and recognition of ill health as well as managing minor illness and referral to other health and care services.


Pharmacy Minister Jo Churchill said: “Highly-skilled community pharmacists are an integral and trusted part of the NHS and we want every patient with a minor illness, or those seeking wellbeing guidance, to think ‘Pharmacy First’.”

NICE says the informal setting of a community pharmacy may encourage people to ask more questions, consider how they feel or how their lifestyle may be affecting their health.

“Community pharmacy teams can offer support with adopting a healthier lifestyle, including stopping smoking, reducing alcohol consumption and managing weight,” the draft document read.

Chief Pharmaceutical Officer Keith Ridge said: “The NHS is making care more easily and conveniently available on the high street, with pharmacists offering more expert services than ever before as part of the NHS Long Term Plan.”

Welcoming the draft quality standard, the Royal Pharmaceutical Society's (RPS) English Pharmacy Board Chair Claire Anderson said: "Community pharmacists are one of the most trusted and accessible health professionals for the public and it’s great to see this draft quality standard recognise the valuable role they play."

"The RPS has long called for community pharmacists to have read-write access to a clinical record and to be better integrated into referral pathways. We’re already seeing some positive steps through Community Pharmacists Consultation Service and look forward to this being expanded, such as through referrals from GPs, to improve patient access and help ease pressure on the health service," Anderson said.

The draft quality standard is open for consultation until February 14, 2020, and the final guidance is expected to be published on June 2, this year.

More For You

Walgreens Boots Alliance acquired by Sycamore in deal

Walgreens Boots Alliancehas entered into “a definitive agreement” to be acquired by Sycamore Partners

Gettyimages

Walgreens Boots Alliance acquired by Sycamore in £18.3 billion deal

Walgreens Boots Alliance(WBA) has entered into “a definitive agreement” to be acquired by Sycamore Partners, a private equity firm specializing in retail, consumer and distribution-related investments.

“The total value of the transaction represents up to $23.7 billion (£18.3 billion),” the company announced late last night (6).

Keep ReadingShow less
Professor Sir Stephen Powis at a press briefing

Professor Sir Stephen Powis, was appointed national medical director of NHS England in 2018

NHS

NHS England’s top doctor to step down following Amanda Pritchard’s resignation

Just a week after NHS England chief executive Amanda Pritchard announced her resignation, the organisation’s national medical director, Professor Sir Stephen Powis, has confirmed he will step down this summer after more than seven years in the role.

In a statement released on Thursday, Professor Powis revealed that he had informed Pritchard of his intention to leave in a letter back in January.

Keep ReadingShow less
PDA calls on GP practices to use funding boost to improve job security for pharmacists

Now, it is time to focus on the community pharmacy contract

gettyimages

PDA urges GP practices to ensure funding boost supports employed pharmacists

The Pharmacists' Defence Association (PDA) has called on GP practicesto ensure that all healthcare professionals they employ, including pharmacists, benefit from the 7.2% funding boost they received under a newly agreed contract.

GP employers are encouraged to improve “job security, pay and conditions” for employees with this increased funding.

Keep ReadingShow less
Fourth Shift: Investment in Innovative Medicines Crucial for NHS 10-Year Plan Success

Medicines should be viewed as an investment rather than a cost

gettyimages

ABPI wants to see a ‘fourth shift’ in NHS 10-Year Health Plan


The Association of the British Pharmaceutical Industry (ABPI) has called on the government to increase investment in innovative medicines and vaccines, describing it as a crucial “fourth shift” necessary to ensure the NHS is fit for the future.

Keep ReadingShow less
Lawrence Tallon named new MHRA chief executive

Lawrence Tallon

Photo credit: Sciana Network

Lawrence Tallon named new MHRA chief executive

Lawrence Tallon has been appointed as the new chief executive officer of the Medicines and Healthcare products Regulatory Agency (MHRA), effective 1 April 2025.

He will succeed Dame June Raine DBE, who is retiring after leading the agency since 2019.

Keep ReadingShow less